<P>&nbsp;</P> <P align=justify>On 5 July 2012, the first stone, marking the start of the construction of the building which will be the home acCInov innovation platform, was officially laid at the very heart of the <A title="" href="https://www.aderly.com/Infectiologie/index,p,157,EN.jsp" target=_blank>Lyonbiop&#244;le</A>, a worldwide cluster focused on the fight against human and animal <A title="" href="https://www.aderly.com/pharmaceutique_biotech/index,p,100044,EN.jsp" target=_blank>infectious diseases and cancers </A>in <A title="" href="https://www.aderly.com/centre-recherche-et/biotechnology-cluster-lyon,p,21,EN.jsp" target=_blank>Lyon-Gerland</A>. Following on from the Centre for Infectious Diseases of the Lyonbiop&#244;le, <STRONG>the acCInov platform will welcome its first occupants as of September 2013</STRONG>. Its <STRONG>4,544 sq. m. net of state of the art technology laboratories and offices</STRONG> will be available to start-up companies as well as to SMEs which need to be able to carry out bio-production and bio-analysis activities. This new innovation platform will therefore <STRONG>triple the space dedicated to running pre-clinical and clinical research projects</STRONG> in the <A title="" href="https://www.aderly.com/biotechnologie-france-europe/life-science-biotechnology-cluster-france-europe,p,6,EN.jsp" target=_blank>biotechnology</A> and biopharmaceutical fields by members of the Lyonbiop&#244;le competitiveness cluster. </P> <P align=justify><BR>Thanks to its original package of services and because it is positioned at <STRONG>the interface between Lyonbiop&#244;le and the "Bio-production by design" platform of the new Technological Research Institute (IRT) BIOASTER</STRONG>, acCInov will be playing a major role in bioproduction <A title="" href="https://www.aderly.com/pepiniere-entreprise/scientific-research-development-france,p,16,EN.jsp" target=_blank>innovation</A> and will bring a large number of players together. This new structure will also add to the economic dynamic and international reputation of Lyonbiop&#244;le, the epicentre in Lyon for industrial development in the field of animal and human health. As a centre of excellence based in Lyon for vaccines and diagnostics, its ambition is <STRONG>to give added impetus to the competitiveness of companies within the <STRONG><A title="" href="https://www.aderly.com/biotechnologie-france-europe/life-science-biotechnology-cluster-france-europe,p,6,EN.jsp" target=_blank>health sector</A><A href="https://www.aderly.com/biotechnologie-france-europe/life-science-biotechnology-cluster-france-europe,p,6,EN.jsp"></STRONG></A><A title="" href="https://www.aderly.com/biotechnologie-france-europe/life-science-biotechnology-cluster-france-europe,p,6,EN.jsp" target=_blank> </A></STRONG>as well as the attractiveness of Lyon region. <STRONG>Aderly is supporting acCInov every step of the way as it launches its new sales offer in France as well as abroad.</STRONG></P> <P align=justify><SPAN style="FONT-FAMILY: ‘Calibri’,’sans-serif’; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: ‘Times New Roman’; mso-ansi-language: EN-US; mso-fareast-language: FR; mso-bidi-language: AR-SA" lang=EN-US></SPAN><BR>&nbsp;</P>